Immunic, Inc. SEC filings IMUX

Immunic, Inc. has 832 filings in SEC EDGAR's recent list, going back to Feb 18, 2004. Its latest annual report, Form 10-K, was filed on Feb 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K/A Amended annual report Apr 22, 2026 Dec 31, 2025
10-K Annual report Feb 26, 2026 Dec 31, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
10-K Annual report Feb 22, 2024 Dec 31, 2023
10-K Annual report Feb 23, 2023 Dec 31, 2022
10-K Annual report Feb 24, 2022 Dec 31, 2021
10-K Annual report Feb 26, 2021 Dec 31, 2020
10-K Annual report Mar 16, 2020 Dec 31, 2019
10-K Annual report Mar 4, 2019 Dec 31, 2018
10-K/A Amended annual report Mar 14, 2018 Dec 31, 2017
10-K Annual report Mar 13, 2018 Dec 31, 2017
10-K Annual report Mar 7, 2017 Dec 31, 2016
10-K Annual report Mar 8, 2016 Dec 31, 2015
ARS Annual report to shareholders Oct 8, 2015 Dec 31, 2014
10-K Annual report Mar 20, 2015 Dec 31, 2014

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IMUX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, United States
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1280776
Former names
VITAL THERAPIES INC (until Apr 10, 2019)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.